Effectiveness and safety of apixaban vs warfarin among venous thromboembolism patients at high-risk of bleeding

This study evaluated effectiveness and safety of apixaban versus warfarin among venous thromboembolism patients at high-risk of bleeding (defined as having at least one of the following bleeding risk factors: ≥75 years; used antiplatelet, NSAIDs, or corticosteroids; had prior gastrointestinal bleedi...

Descripción completa

Detalles Bibliográficos
Autores principales: Cohen, Alexander T., Sah, Janvi, Dhamane, Amol D., Lee, Theodore, Rosenblatt, Lisa, Hlavacek, Patrick, Emir, Birol, Keshishian, Allison, Yuce, Huseyin, Luo, Xuemei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Public Library of Science 2022
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506658/
https://www.ncbi.nlm.nih.gov/pubmed/36149864
http://dx.doi.org/10.1371/journal.pone.0274969

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9506658/
https://www.ncbi.nlm.nih.gov/pubmed/36149864
http://dx.doi.org/10.1371/journal.pone.0274969

Ejemplares similares